{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:55:05Z","timestamp":1761630905890,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.dld.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T08:55:27Z","timestamp":1586508927000},"page":"604-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1133-1502","authenticated-orcid":false,"given":"Fabiana","family":"Zingone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Buda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Mar 4","key":"10.1016\/j.dld.2020.04.004_bib0001","article-title":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths","author":"Lai","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"Mar 5","key":"10.1016\/j.dld.2020.04.004_bib0002","article-title":"Taking the right measures to control COVID-19","author":"Xiao","year":"2020","journal-title":"Lancet Infect Dis."},{"issue":"Mar 3","key":"10.1016\/j.dld.2020.04.004_bib0003","article-title":"COVID-19: gastrointestinal manifestations and potential fecal-oral transmission","author":"Gu","year":"2020","journal-title":"Gastroenterology"},{"issue":"Mar 3","key":"10.1016\/j.dld.2020.04.004_bib0004","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.04.004_bib0005","unstructured":"1st Interview COVID-19 ECCO Taskforce. ECCO crisis task force. https:\/\/www.ecco-ibd.eu\/images\/6_Publication\/6_8_Surveys\/1st_interview_COVID-19%20ECCOTaskforce_published.pdf (Accessed 13 March 2020)."},{"key":"10.1016\/j.dld.2020.04.004_bib0006","unstructured":"2nd Interview COVID-19 ECCO Taskforce. https:\/\/ecco-ibd.eu\/images\/6_Publication\/6_8_Surveys\/2nd_Interview_COVID-19_ECCO_Taskforce_published.pdf (Accessed 20 March 2020)"},{"issue":"Mar 17","key":"10.1016\/j.dld.2020.04.004_bib0007","article-title":"What should gastroenterologists and patients know about COVID-19?","author":"Ungaro","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.04.004_bib0008","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.dld.2020.04.004_bib0009","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/ajg.2013.138","article-title":"Opportunistic infections with anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials","volume":"108","author":"Ford","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.dld.2020.04.004_bib0010","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/ajg.2016.433","article-title":"Crohn's disease activity and concomitant immunosuppressants affect the risk of serious and opportunistic infections in patients treated with adalimumab","volume":"111","author":"Osterman","year":"2016","journal-title":"Am J Gastroenterol."},{"issue":"Jan 13","key":"10.1016\/j.dld.2020.04.004_bib0011","article-title":"First- and Second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis","author":"Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.04.004_bib0012","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00535-012-0686-9","article-title":"A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"48","author":"Naganuma","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2020.04.004_bib0013","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"issue":"Mar 25","key":"10.1016\/j.dld.2020.04.004_bib0014","article-title":"Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak","author":"Zingone","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"Mar 16","key":"10.1016\/j.dld.2020.04.004_bib0015","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","author":"Meta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2020.04.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30691-7","article-title":"Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?","author":"Ritchie","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2020.04.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","author":"To","year":"2020","journal-title":"Lancet Infect Dis."}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820301389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820301389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:12:27Z","timestamp":1761624747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865820301389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1590865820301389"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2020.04.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}